Evidence map›Paper›PMID 23828942›Full record

ReviewScience (New York, N.Y.)2013

Somatic mutation, genomic variation, and neurological disease.

Annapurna Poduri, Gilad D Evrony, Xuyu Cai, Christopher A Walsh

Abstract readReview
In one paragraph

Review in Science (New York, N.Y.), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 309 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
309citing papers in PubMed, 1 pooled it
48.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

309 citing papers in PubMed, 1 synthesis or guideline pooled it, 603 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Clinical relevance of mosaic variants detected by exome sequencing.The Journal of allergy and clinical immunology · 2026
    Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Early death and neuronal abnormalities inbioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

249 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Annapurna PoduriDepartment of Neurology, Boston Children's Hospital, Boston, MA 02115, USA.
Gilad D Evrony
Xuyu Cai
Christopher A Walsh
Harvard University · USBoston Children's Hospital · US

Funding

Medical Scientist Training ProgramT32GM007753 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WALENSKY, LOREN DAVID · 1985 to 2021
$50.0M
Molecular, Cellular, & Developmental Dynamics PhD ProgramT32GM007226 · NIGMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI VAN VACTOR, DAVID L. · 1985 to 2021
$14.4M
Cell Identity Determination In Human Brain: Somatic Mutation and Cell LineageR01NS032457 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Alice Eunjung Lee, Christopher A. Walsh · 1995 to 2026
$12.7M
HUMAN EPILEPSY GENETICS--NEURONAL MIGRATION DISORDERSR01NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 1997 to 2023
$9.5M
Finding Autism Genes by Genomic Copy Number AnalysisR01MH083565 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 2007 to 2016
$6.9M
Human Epilepsy Genetics Neuronal Migration DisordersR37NS035129 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI Christopher A. Walsh · 2002 to 2026
$6.5M
Human autism genetics and activity dependent gene activationRC2MH089952 · NIMH · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 2009 to 2010
$5.1M
Somatic mutations in epilepsy: whole genome sequence analysis of single neuronsR01NS079277 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI WALSH, CHRISTOPHER A. · 2012 to 2015
$1.4M
Genetics of Familial Epilepsy SyndromesK23NS069784 · NINDS · BOSTON CHILDREN'S HOSPITAL · PI PODURI, ANNAPURNA · 2010 to 2014
$901k
Howard Hughes Medical InstituteNIGMS NIH HHS T32 GM007226NIGMS NIH HHS T32GM007726-35NIGMS NIH HHS T32 GM007753NIGMS NIH HHS T32GM007753NIMH NIH HHS 1RC2MH089952NIMH NIH HHS R01 MH083565NIMH NIH HHS RC2 MH089952NINDS NIH HHS K23 NS069784NINDS NIH HHS K23NS069784NINDS NIH HHS R01 NS032457NINDS NIH HHS R01 NS035129NINDS NIH HHS R01 NS079277NINDS NIH HHS R37 NS035129
6 · The paper itself

Abstract

Genetic mutations causing human disease are conventionally thought to be inherited through the germ line from one's parents and present in all somatic (body) cells, except for most cancer mutations, which arise somatically. Increasingly, somatic mutations are being identified in diseases other than cancer, including neurodevelopmental diseases. Somatic mutations can arise during the course of prenatal brain development and cause neurological disease-even when present at low levels of mosaicism, for example-resulting in brain malformations associated with epilepsy and intellectual disability. Novel, highly sensitive technologies will allow more accurate evaluation of somatic mutations in neurodevelopmental disorders and during normal brain development.

Indexed as

MutationBrain DiseasesCerebral CortexClassical Lissencephalies and Subcortical Band HeterotopiasDNA Mutational AnalysisHigh-Throughput Nucleotide SequencingHumansLissencephalyMosaicism

Identifiers

PMID23828942
PMCPMC3909954
OpenAlexW2086289230

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.